Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:09 pm Purchase | 2021-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Palo Alto Investors LP | 364,697 7.240% | 13,520 (+3.85%) | Filing History |
| 2022-02-11 4:01 pm Sale | 2021-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Kauffman Michael | 271,888 5.200% | -10,209 (-3.62%) | Filing History |
| 2022-02-11 2:54 pm Sale | 2021-12-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Chione Ltd. | 333,333 6.600% | -33,334 (-9.09%) | Filing History |
| 2022-02-11 08:38 am Sale | 2021-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | STATE STREET CORP STT | 367,579 7.300% | -167,088 (-31.25%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 594,547 11.800% | 0 (Unchanged) | Filing History |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 594,547 11.800% | 96,207 (+19.31%) | Filing History |
| 2021-10-12 12:23 pm Purchase | 2021-09-30 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | STATE STREET CORP STT | 534,667 10.620% | 178,676 (+50.19%) | Filing History |